Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ) has shared an announcement.
Fusen Pharmaceutical Company Limited, a company incorporated in the Cayman Islands, has announced a change in the date of its board meeting. Originally scheduled for March 28, 2025, the meeting has been postponed to March 31, 2025, to allow additional time for finalizing the company’s annual results for the year ended December 31, 2024. This delay may impact the timing of the approval and publication of the annual results and the consideration of a final dividend.
More about Fusen Pharmaceutical Co., Ltd.
YTD Price Performance: -65.62%
Average Trading Volume: 454,837
Technical Sentiment Signal: Buy
Current Market Cap: HK$202.2M
For detailed information about 1652 stock, go to TipRanks’ Stock Analysis page.